Breaking Down Akerna Corp. (KERN) Financial Health: Key Insights for Investors

Breaking Down Akerna Corp. (KERN) Financial Health: Key Insights for Investors

US | Healthcare | Medical - Healthcare Information Services | NASDAQ

Akerna Corp. (KERN) Bundle

Get Full Bundle:
$9 $7
$9 $7
$9 $7
$9 $7
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Curious whether Akerna Corp. (KERN) is a turnaround candidate or a cautionary tale? This deep-dive teases out the numbers: $18.2 million in 2022 revenue from compliance services (a 15% year-over-year rise), a commanding 22% slice of an estimated $540 million cannabis compliance software market, and $8.3 million in ARR reported in Q2 2023-yet juxtaposed with a $12.5 million net loss in 2022, ROE of -2.22%, operating margin of -1.21%, and negative free cash flow of $2.7 million; liquidity and capital structure metrics further complicate the picture, from a 0.66 current ratio and only $877,750 in cash (2022) to a debt-to-assets ratio of 124.79% and a market cap of $3.25 million, while valuation gauges show an intrinsic value of -$128.62 versus a market price of $0.31 and a P/E of -3.43-against this backdrop analysts still project revenue reaching $30 million by 2025 (CAGR ≈36%), supported by an 85% customer retention rate, ~1,200 clients, long-term contracts and strategic partnerships; read on to see how these figures translate into risks, leverage, liquidity and real growth potential.

Akerna Corp. (KERN) - Revenue Analysis

Akerna Corp. (KERN) derives the bulk of its top-line from compliance and cannabis technology services. Recent reported figures and market-share estimates frame a growth story tied closely to the cannabis compliance niche and a set of long-term contracts that underpin recurring revenue.
  • 2022 compliance services revenue: $18.2 million (reported; ~15% year-over-year growth).
  • Estimated market share: ~22% of the cannabis compliance software market (total market ≈ $540 million).
  • Q2 2023 reported ARR from long-term contracts: ≈ $8.3 million.
  • Analyst revenue projection for 2025: $30 million (implied CAGR ≈ 36% from 2022 baseline).
  • Revenue concentration: primarily in cannabis technology with limited diversification outside the sector.
  • Revenue stability supported by partnerships with various cannabis-related businesses.
Metric Value Notes
2022 Revenue (compliance services) $18.2 million Reported; ~15% YoY growth
Market Size (cannabis compliance software) $540 million Industry estimate
Company Market Share 22% Implied ~ $118.8 million share of TAM if fully non-overlapping product set
Q2 2023 ARR $8.3 million From long-term contracts
Analyst 2025 Revenue Projection $30 million Implied CAGR ≈ 36% (2022→2025)
Revenue Diversification Low Concentrated in cannabis technology
  • Revenue drivers: recurring ARR from long-term contracts, expansion within existing cannabis operator customers, and partner-driven channel sales.
  • Risks to growth: heavy sector concentration and potential regulatory/market volatility in cannabis.
  • Opportunities: capturing additional share of a $540M market and cross-selling new compliance/tech modules to existing customers.
Exploring Akerna Corp. (KERN) Investor Profile: Who's Buying and Why?

Akerna Corp. (KERN) - Profitability Metrics

Akerna Corp. (KERN) shows continued profitability pressure across multiple measures, with recent results underscoring operating inefficiencies and limited returns for shareholders.
Metric Value (2022) Interpretation
Net Income / (Loss) $(12.5) million Reported net loss for 2022
Return on Equity (ROE) -2.22% Negative shareholder return generation
Operating Margin -1.21% Core operations not producing positive margins
Net Profit Margin -4.30% Losses relative to revenue
Return on Assets (ROA) -3.01% Inefficient asset utilization
Free Cash Flow Negative Limited financial flexibility for reinvestment
  • Net loss of $12.5M constrains retained earnings and equity rebuild.
  • Negative ROE (-2.22%) signals the company is destroying shareholder value rather than creating it.
  • Operating margin at -1.21% indicates core business costs exceed operating revenues.
  • Net profit margin of -4.30% confirms company-wide unprofitability after all expenses.
  • ROA of -3.01% shows assets are underperforming versus peers that convert assets to profit.
  • Negative free cash flow reduces ability to fund growth initiatives without external financing.
For further context on ownership, activity and investor interest that ties into these profitability dynamics see: Exploring Akerna Corp. (KERN) Investor Profile: Who's Buying and Why?

Akerna Corp. (KERN) - Debt vs. Equity Structure

Akerna Corp. (KERN) shows a capital structure dominated by liabilities rather than equity, with several red flags for liquidity and leverage that investors must weigh carefully.
  • Enterprise Value (Nov 2025): $13.89 million - a steep decline from the historical average EV of $485.74 million.
  • Market Capitalization: $3.25 million with 10.35 million outstanding shares.
  • Debt-to-Assets (2022): 124.79% - debt exceeded reported assets that year.
  • Debt-to-Equity: -3.03 - reflecting negative equity or accounting distortions where liabilities materially exceed shareholder equity.
  • Current Ratio: 0.66 - below the 1.0 threshold, indicating potential short-term liquidity stress.
  • Liabilities change: down 30% year-over-year - management has reduced nominal liabilities, which partially mitigates prior leverage concerns.
Metric Value Context / Implication
Enterprise Value (Nov 2025) $13.89M Far below historical EV ($485.74M) - market has materially repriced the business.
Market Capitalization $3.25M Equity market value is extremely low relative to liabilities.
Outstanding Shares 10.35M Share count used to derive per-share metrics and dilution risk.
Debt-to-Assets (2022) 124.79% Indicates debt exceeded assets - raises solvency concerns for that period.
Debt-to-Equity -3.03 Negative equity signal - capital structure heavily reliant on debt or past losses.
Current Ratio 0.66 Below 1.0 - potential inability to cover near-term obligations with current assets.
Liabilities YoY change -30% Meaningful deleveraging effort, improving balance sheet runway if sustained.
Key investor considerations include credit risk, potential equity dilution if management raises capital, and the pace of deleveraging relative to operating cash flow. For additional context on shareholder composition and buying trends, see Exploring Akerna Corp. (KERN) Investor Profile: Who's Buying and Why?

Akerna Corp. (KERN) - Liquidity and Solvency

Akerna Corp. (KERN) shows strained short-term liquidity and pressured solvency metrics driven by shrinking cash balances, negative cash flows and elevated leverage.
  • Current ratio: 0.66 - indicates potential difficulty meeting short-term obligations.
  • Quick ratio: Not specified - low current ratio implies quick ratio is also likely weak.
  • Cash & cash equivalents: $877,750 (2022) vs. $13.93 million (2021) - a sharp year-over-year decline.
  • Free cash flow: -$2.70 million - negative, limiting reinvestment and debt reduction capacity.
  • Operating cash flow: Negative - core operations are not generating sufficient cash.
  • Solvency: Under pressure due to high debt levels combined with negative cash flow metrics.
Metric Value / Note
Current ratio 0.66
Quick ratio Not specified
Cash & cash equivalents (2022) $877,750
Cash & cash equivalents (2021) $13,930,000
Free cash flow -$2,700,000
Operating cash flow Negative (not specified)
Total debt / liabilities High / pressure on solvency (not fully specified)
  • Immediate liquidity risk: Low cash balance and current ratio below 1.0 increase the risk of needing external financing or asset disposals to meet near-term liabilities.
  • Operational strain: Negative operating cash flow and negative free cash flow reduce internal options for growth investments or debt repayment.
  • Financing implications: High debt combined with poor cash generation elevates refinancing risk and could increase borrowing costs or equity dilution if capital is raised.
  • Monitoring priorities for investors: cash runway, changes in operating cash flow, any debt maturities or covenant triggers, and disclosures about planned financing or cost reductions.
Akerna Corp. (KERN): History, Ownership, Mission, How It Works & Makes Money

Akerna Corp. (KERN) - Valuation Analysis

  • Intrinsic value (11/05/2025): -$128.62 vs. market price $0.31 - headline signal interpreted as market pricing above computed intrinsic value.
  • P/E (TTM, 10/31/2025): -3.43 - negative earnings per share drive the negative multiple.
  • EV/EBITDA: 1.15 - a low ratio on paper but reflecting negative EBITDA in the denominator.
  • P/B: -0.19 - market capitalization below reported book equity, producing a negative book multiple.
  • Zacks Consensus Estimate: +20.4% revision upward over the past three months - analysts have been raising forward estimates.
  • Operating cash flow and net income: negative (periods through late 2025), creating valuation and solvency concerns despite some low relative multiples.
Metric Value Period / Date Interpretation
Intrinsic Value (per share) -$128.62 11/05/2025 Model indicates negative intrinsic equity per share
Market Price (per share) $0.31 11/05/2025 Current trading price
P/E (TTM) -3.43 10/31/2025 Negative earnings; P/E not meaningful for valuation comparables
EV/EBITDA 1.15 Latest reported Low ratio but EBITDA negative - interpret with caution
P/B -0.19 Latest reported Implies market cap below book value
Zacks Consensus Estimate Change +20.4% Past 3 months Analysts have raised forward estimates
Cash Flow / Net Income Negative Through late 2025 Impairs sustainable valuation recovery
  • Why metrics conflict: negative earnings and cash flow can produce low or distorting multiples (e.g., EV/EBITDA near 1.15 despite negative EBITDA), and negative book or intrinsic computations create counterintuitive signals versus market price.
  • Investor considerations:
    • Balance sheet/book value exposure given P/B below zero;
    • Operational turnaround required to justify market price or any positive intrinsic re-rating;
    • Analyst estimate upgrades (Zacks +20.4%) may reflect expected revenue/efficiency improvements but must be weighed against continuing negative cash generation.
Akerna Corp. (KERN): History, Ownership, Mission, How It Works & Makes Money

Akerna Corp. (KERN) - Risk Factors

Akerna Corp. (KERN) faces a concentrated set of risks that materially affect its financial health and investor outlook. Below are the principal risk categories, illustrated with key metrics and context where available.
  • Regulatory risk: Akerna operates almost exclusively in the cannabis industry, which remains fractured across federal, state and international regulatory regimes. Material changes in federal or state regulation (licensing, banking, interstate commerce, taxation) can reduce addressable market size, delay client deployments, or add compliance costs.
  • Competitive pressure: The company competes with 50+ cannabis technology and compliance vendors, creating pricing pressure and margin compression. Competitive pricing and feature parity can force Akerna to increase sales and marketing spend to retain and win clients.
  • Customer concentration: Akerna derives a significant portion of revenue from a small group of large clients. Loss or reduced usage by one or more of these customers could cause a sizable revenue decline in a quarter.
  • Cybersecurity and technology disruption: Cannabis companies are increasingly targeted-cyber-attacks on cannabis-related firms rose ~20% in 2021-exposing Akerna to data loss, downtime, remediation costs and reputational damage.
  • Sector concentration: Limited diversification beyond cannabis leaves Akerna highly sensitive to sector-specific downturns (e.g., regulatory headwinds, slower cannabis market growth, macro-driven demand shocks).
  • Financial instability: The company has recorded recurring operating losses and negative operating cash flows, creating ongoing financing and liquidity risk that can limit strategic flexibility.
Metric Fiscal Year / Latest Report Value Implication
Revenue FY 2023 (reported) $28.4M Relatively small scale; limits margin absorption on fixed costs.
Net Loss FY 2023 (reported) -$46.1M Significant operating losses reflect high opex vs. revenue.
Operating Cash Flow FY 2023 -$35.2M Negative cash flow requiring external financing or cash preservation.
Cash & Cash Equivalents As of latest quarter $12.5M Limited runway without additional capital or improved cash generation.
Total Liabilities As of latest quarter $52.0M Leverage pressure relative to cash resources.
Revenue from Top 5 Clients Trailing 12 months ~45% Concentration risk: losing major clients would sharply reduce topline.
Competitor Count Market estimate 50+ Fragmented market increases go-to-market costs and churn risk.
Cyber-attack Trend 2021 industry stat +20% attacks y/y Elevated expected security spend and incident risk.
  • Liquidity & financing risk: Given persistent operating losses and negative cash flow, Akerna may need to raise capital through equity or debt at potentially dilutive or expensive terms; access to capital markets is sensitive to market sentiment toward cannabis and tech stocks.
  • Execution risk: Scaling SaaS deployments across disparate cannabis operators requires continued product investment, high service quality and regulatory adaptation; execution missteps can increase churn and slow new sales.
  • M&A and integration risk: Growth through acquisitions is common in the space; consolidations can introduce integration costs and distract management from organic growth initiatives.
For additional context on corporate purpose and strategic orientation, see: Mission Statement, Vision, & Core Values (2026) of Akerna Corp.

Akerna Corp. (KERN) - Growth Opportunities

Akerna Corp. (KERN) has positioned itself to capture continued upside in the cannabis compliance software market through a mix of stable contract revenue, targeted R&D, and strategic partnerships. Core drivers include long-term contracts with cannabis-related businesses that support predictable revenue streams and a dominant market position representing roughly 22% of an estimated $540 million total market.
  • Market position: ~22% share of the $540M cannabis compliance software market (~$118.8M share-of-market equivalent).
  • Revenue trajectory: analysts project revenue reaching $30M by 2025, implying a CAGR of ~36% from current bases used in those estimates.
  • Customer base and retention: >1,200 clients with an 85% retention rate, underpinning recurring revenue potential.
Metric Value Notes
Market size (cannabis compliance software) $540,000,000 Estimated total addressable market
Akerna market share 22% Company-reported/industry estimate
Implied share-dollar $118,800,000 22% of $540M
Projected revenue (2025) $30,000,000 Analyst projection
Projected revenue CAGR ~36% Through 2025 based on projection
Customers 1,200+ Active client count
Customer retention 85% High recurring revenue visibility
Expected uplift in average customer spend +20% over 2 years Linked to R&D in data analytics
Akerna's strategic partnerships across the cannabis supply chain have been pivotal, enabling cross-sell opportunities and deeper integrations that increase customer stickiness. Investment in data analytics and product enhancements is intended to drive higher average revenue per user (ARPU) and expand addressable offerings.
  • Partnerships: integrations with industry leaders to expand distribution and embed compliance workflows.
  • R&D focus: advanced analytics aimed at increasing average customer spend ~20% within two years.
  • Revenue stability: long-term contracts and 85% retention reduce churn-related volatility.
For further context on investors and recent buying trends: Exploring Akerna Corp. (KERN) Investor Profile: Who's Buying and Why?

DCF model

Akerna Corp. (KERN) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.